Viewing Study NCT05789303


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-06-04 @ 7:15 PM
Study NCT ID: NCT05789303
Status: RECRUITING
Last Update Posted: 2025-12-22
First Post: 2023-03-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
Sponsor: University of Chicago
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Relapse Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None multiple myeloma View